Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00803335 · ClinicalTrials.gov registry record · Phase 3
The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse
A Phase 3 study, sponsored by TriHealth.
- Completed
- Registry status
- Phase 3
- Development phase
- 54
- Enrollment target
NCT00803335 is a Phase 3 study that has completed, run by TriHealth. The registered enrollment target is 54 participants.
The verdict
NCT00803335, a Phase 3 study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to find out how long it takes the vagina to respond to hormonal vaginal cream in women with pelvic organ prolapse (bulge in the vagina). It also will address the appropriate amount to use prior to vaginal repair of pelvic organ prolapse.
Interventions
- DRUG Vaginal conjugated estrogen cream 0.5gm
- DRUG Vaginal conjugated estrogen cream 1.0gm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00803335
The ClinicalTrials.gov registry entry for NCT00803335 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vaginal conjugated estrogen cream 0.5gm is the first listed.
NCT00803335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00803335 about?
NCT00803335 is a clinical study titled "The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse". The purpose of this study is to find out how long it takes the vagina to respond to hormonal vaginal cream in women with pelvic organ prolapse (bulge in the vagina). It also will address the appropriate amount to use prior to vaginal repair of pelvic organ prolapse.
What is the current status of trial NCT00803335?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 54 participants. The study started on 2008-12. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00803335?
The interventions under investigation include: Vaginal conjugated estrogen cream 0.5gm (DRUG), Vaginal conjugated estrogen cream 1.0gm (DRUG).
Who is sponsoring clinical trial NCT00803335?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.